Targeting Plasma Cells in Autoimmune Diseases

Antibodies specific for self-antigens mediate life-threatening pathology in several autoimmune diseases. Clearly the ability to target the plasma cells (PCs) producing the autoantibodies would be of great clinical benefit. Current immunosuppressive therapies are based on the premise that autoreactiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarlinton, David M., Hodgkin, Philip D.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2004
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211780/
https://www.ncbi.nlm.nih.gov/pubmed/15173204
http://dx.doi.org/10.1084/jem.20040719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211780/
https://www.ncbi.nlm.nih.gov/pubmed/15173204
http://dx.doi.org/10.1084/jem.20040719

Ejemplares similares